These highlights do not include all the information needed to use Risperidone safely and effectively. see full prescribing information for Risperidone. Risperidone (Risperidone) SOLUTION for ORAL use. Initial U.S. Approval: 1993
ثبت نشده
چکیده
INDICATIONS AND USAGE Risperidone oral solution, USP is an atypical antipsychotic agent indicated for: (1) Treatment of schizophrenia in adults and adolescents aged 13 to 17 years (1.1) Alone, or in combination with lithium or valproate , for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in adults, and alone in children and adolescents aged 10 to 17 years (1.2) Treatment of irritability associated with autistic disorder in children and adolescents aged 5 to 16 years (1.3)
منابع مشابه
Warning: Increased Mortality in Elderly Patients with Dementia-related Psychosis
• Efficacy was established with Symbyax (olanzapine and HIGHLIGHTS OF PRESCRIBING INFORMATION fluoxetine in combination) in adults; refer to the product label These highlights do not include all the information needed to use for Symbyax. ZYPREXA safely and effectively. See full prescribing information for ZYPREXA. ------------------------DOSAGE AND ADMINISTRATION---------------------- ZYPREXA ...
متن کاملRISPERDAL (risperidone) tablets, for oral use RISPERDAL (risperidone) oral solution RISPERDAL M-TAB (risperidone) orally disintegrating tablets Initial U.S. Approval: 1993 WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
Severe Renal or Hepatic Impairment in Adults: Use a lower starting dose of 0.5 mg twice daily. May increase to dosages above 1.5 mg twice daily at intervals of at least one week. (2.4) Oral Solution: Can be administered directly from calibrated pipette or mixed with beverage (water, coffee, orange juice, or low-fat milk). (2.6) M-TAB Orally Disintegrating Tablets: Open the blister only wh...
متن کاملWarning: Suicidality and Antidepressant Drugs and Increased Mortality in Elderly Patients with Dementia-related Psychosis
• Do not use with thioridazine due to QTc interval prolongation or HIGHLIGHTS OF PRESCRIBING INFORMATION potential for elevated thioridazine plasma levels. Do not use These highlights do not include all the information needed to use thioridazine within 5 weeks of discontinuing SYMBYAX (4, 7.7) SYMBYAX safely and effectively. See full prescribing information for SYMBYAX. -----------------------W...
متن کاملMobic® (meloxicam) tablets and oral suspension
HIGHLIGHTS OF PRESCRIBING INFORMATION -----------------------WARNINGS AND PRECAUTIONS----------------------- These highlights do not include all the information needed to use MOBIC Serious and potentially fatal cardiovascular (CV) thrombotic events, safely and effectively. See full prescribing information for MOBIC. myocardial infarction, and stroke. Patients with known CV disease/risk facto...
متن کاملZestril (lisinopril) tablets, for oral use lABEL
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZESTRIL safely and effectively. See full prescribing information for ZESTRIL Zestril (lisinopril) tablets, for oral use Initial U.S. Approval: 1988 WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue Zestril as soon as...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016